课题基金 / 基金详情

Immuno-Melecular characterization of lymphocyte functioning antigen (LFA)

Immuno-Melecular characterization of lymphocyte functioning antigen (LFA)
淋巴细胞功能抗原 (LFA) 的免疫分子特征
批准号:
01480194
负责人:
OKUMURA Ko
金额:
$3.65万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1991

项目摘要

项目成果

OKUMURA Ko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cell interactions in the immune system are mediated by several different families of receptors on cell surface, and these adhesion molecules influence many diverse processes including, differentiation, migration and cellular activation. To understand in vivo significance of these molecules in various and immunological phenomenon, we have been mainly, focussing murine as well as rat experimental systems. We report the experimental results performed to understand the role of VLA-4, LFA-1, and ICAM-1 in cell migration and activation in rat and mouse experimental systems.(1) Anti-rat VLA-4 mAb, which we established, could inhibit lymphocyte homing to Payeris patch selectively.(2) Anti-rat VLA-4- mAb inhibited the infiltration of lymphocytes, monocytes and eosinophils but not neutrophils to inflamatory sites.(3) Fibronectin acted costimulatory in FceRI-mediated activation of rat mast cells. This costimlatory effect was mainly mediated by VLA-4.(4) Anti-VLA-4 mAb prevented the cardiac allograft rejection more strongly than anti-LFA-1 mAb.(5) Mixed administration of inti-LFA-1 and anti-ICAM-1 mAbs caused specific cardiac allograft tolerance in both murine and rat systems.
期刊论文(54)
专著(0)
科研奖励(0)
会议论文
Nakamura,T.,Takahashi,K.,Koyanagi,M.,Y.,et al.: "Acivation of a natural killer clonc upon target cell binding via CD2." Eur.J.Immunol.21. 831-834 (1991)
Nakamura,T.、Takahashi,K.、Koyanagi,M.、Y.等人:“通过 CD2 结合靶细胞后激活自然杀伤克隆。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahashi, K., Nakata, M., Tanaka, T., et al.: "CD4 an CD8 regulate IL-2 response of T cells : Involvement of p56^<1ck>." Proc. Natl. Acad. Sci.(1992)
Takahashi, K.、Nakata, M.、Tanaka, T. 等人:“CD4 和 CD8 调节 T 细胞的 IL-2 反应:p56^<1ck> 的参与。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahashi,K.,Nakata,M.,Tanaka,T.,et al.: "CD4 and CD8 regulate ILー2 response of T cells:Involvement of p56^<1ck>." Proc.Natl.Acad.Sci.(1992)
Takahashi, K.、Nakata, M.、Tanaka, T. 等人:“CD4 和 CD8 调节 T 细胞的 IL-2 反应:p56^<1ck> 的参与。” 1992)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Taizo Nitta: "Bispecific F(ab')_2monomer prepared with antiーCD3 and antiーtumor monoclonal ant ibodies is most potent in induction of cytolysis of human T cells." Eur,J.Immunol.19. 1437-1441 (1989)
Taizo Nitta:“用抗 CD3 和抗肿瘤单克隆抗体制备的双特异性 F(ab)_2 单体在诱导人类 T 细胞细胞溶解方面最为有效。”Eur,J.Immunol.1989。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
26
    Development of the antibody medical treatment to autoimmune and asthmatic diseases based on new target molecule.
    • 批准号:
      23390260
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2011
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Studies on wetting and fracture based on the spirit of impressionistic physics
    • 批准号:
      20340110
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.74万
    • 财政年份:
      2008
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Development of strategy to treat allergic diseases via targeting surface molecules on lymphocytes and intracellular signaling molecules
    • 批准号:
      20390282
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2008
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    Statistical analyses of allergy-related polymorphisms
    • 批准号:
      07F07462
    • 项目类别:
      Grant-in-Aid for JSPS Fellows
    • 资助金额:
      $1.47万
    • 财政年份:
      2007
    • 负责人:
      OKUMURA Ko
    • 依托单位:
    国内基金
    海外基金
    阻断LFA-1/VLA-4通路抑制CAR-T细胞中靶脱瘤毒性并增强T细胞记忆功能的机制研究
    • 批准号:
      82373249
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      翟博
    • 依托单位:
    从DLI探索靶向干预VLA-4促进Allo-HSCT后HSC植入的作用及机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      宋献民
    • 依托单位:
    HIF-1α-SDF-1/CXCR4-VLA4在DS/CU靶向杀伤AML干细胞的作用及机制研究
    • 批准号:
      81400104
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      23.0万元
    • 批准年份:
      2014
    • 负责人:
      郭绪涛
    • 依托单位:
    VLA-4 基因表达的调控及其在骨髓瘤抗药性中的作用
    • 批准号:
      81071743
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2010
    • 负责人:
      李志伟
    • 依托单位: